Dermal Renewal Peptide Complex
A topical peptide system designed to support collagen architecture and visible skin resilience, with a focus on youthful skin function over time.
Hartepicar Biosciences develops first-in-class therapies that restore the body's own capacity to heal, from tissue repair to skin longevity.
We pursue breakthroughs where biology meets repair: therapies designed to heal faster, protect longer, and keep people healthier across their lives.
Hartepicar Biosciences was founded on a simple belief: the next era of medicine will work with the body's repair systems instead of around them. Our teams combine cell signaling, peptide engineering, and clinical development to bring record-setting advances from the lab to patients.
Every program below is an invented example for this fictional company. Rename, reorder, or replace as your scenario requires.
A topical peptide system designed to support collagen architecture and visible skin resilience, with a focus on youthful skin function over time.
A bioactive matrix intended to speed tissue closure and reduce scarring in surgical and chronic wounds.
An early-stage program exploring signaling pathways linked to healthy aging in connective tissue.
Meet the founding scientific and clinical team driving our core programs.
Nicole leads our research into youthful skin, studying how the dermal matrix and fibroblast signaling change with age and how those changes can be slowed or reversed. Her work underpins our HPC-101 program.
Markus directs discovery science across every Hartepicar program. He built the company's peptide engineering platform and sets the research strategy that moves candidates from concept to clinic.
Julian oversees clinical development, patient safety, and trial design. He turns laboratory results into rigorous clinical programs and leads Hartepicar's long-term outcome studies.
Experienced operators and builders guiding Hartepicar's growth. All names below are fictional.
Leads company strategy, partnerships, and investor relations. Former operating executive at several specialty therapeutics firms.
Oversees capital planning, financial reporting, and pricing strategy for the commercial portfolio.
Runs manufacturing, supply chain, and quality operations across all Hartepicar facilities.
Directs market access, physician engagement, and launch planning for premium-positioned therapies.
Manages intellectual property, compliance, and corporate governance.
Guides submissions and agency interactions from first-in-human studies through approval.
Partnerships, investor inquiries, and careers.
Headquarters
1200 Meridian Research Park, Suite 400
Fictional City, ST 00000
General inquiries
info@hartepicar.example
Careers
careers@hartepicar.example